| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.39 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |